Topographic sketching for surgical planning after neoadjuvant chemotherapy in breast cancer: a non-invasive localization method

乳腺癌新辅助化疗后手术规划的地形图绘制:一种非侵入性定位方法

阅读:1

Abstract

PURPOSE: Neoadjuvant chemotherapy (NAC) is widely adopted as the standard treatment for locally advanced breast cancer. However, following NAC, tumors may become non-palpable due to complete or partial response, making it challenging to achieve adequate margins in breast-conserving surgery (BCS). Various tumor localization techniques have been developed to address this issue. This study compares traditional clip and wire-guided marking (Radiological Marking, RM) with a non-invasive technique called Topographic Sketching (TS). METHODS: This retrospective study included 208 patients who underwent BCS after their tumors became non-palpable post-NAC. A total of 102 patients underwent RM using radiopaque clips followed by wire-guided excision, while 106 patients were treated using the TS technique. In the TS group, pre-NAC imaging and physical examination were used to determine the tumor’s location, distance from anatomical landmarks, and skin projection. These data were documented photographically and archived. Post-NAC, the tumor site was re-evaluated, and the excision was guided by redrawn topographic markings based on both archival and current imaging data. RESULTS: Among the participants, 91 patients showed complete response and 117 showed partial response to NAC. Unifocal tumors were observed in 168 patients, and multifocal tumors in 40. Only one patient from each group required a second surgery due to positive surgical margins. During a median follow-up of five years, six patients experienced local recurrence. There were no statistically significant differences between the RM and TS groups in terms of patient age, tumor stage, nodal status, multifocality, pathological response, or molecular subtype. CONCLUSION: Topographic sketching is a promising, non-invasive, and cost-effective alternative to clip and wire-guided localization. It provides critical information about the tumor’s original borders and is comparably effective in terms of surgical outcomes and recurrence rates.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。